Adjunctive Study of AL-37807 Ophthalmic Suspension

Comparison of Safety and Efficacy of Al-37807 Ophthalmic Suspension vs. Timolol Gel Forming Solution and Vehicle, All Dosed Concomitantly With Xalatan in Patients With Open-Angle Glaucoma or Ocular Hypertension

The purpose of the study is to compare the safety and intraocular pressure-lowering efficacy of AL-37807 ophthalmic suspension vs. Timolol gel forming solution vs. AL-37807 vehicle, all dosed concomitantly with Xalatan, in patients with open-angle glaucoma or ocular hypertension.

Inclusion Criteria:

• Open-angle glaucoma
• Ocular hypertension
• Must have been on Xalatan for at least 3 months
• VA not worse than 0.60
• Other protocol-defined inclusion criteria may apply

Exclusion Criteria:

• Age related
• Other protocol-defined exclusion criteria may apply